Aniracetam is a nootropic supplement that stimulates AMPA receptors in the brain, improving mental function. It is sold as a prescription drug in Europe and a dietary supplement in the US, and is similar to piracetam but more potent. Ampacins, which are derived from aniracetam, have potential as treatments for Parkinson’s, Alzheimer’s, and ADHD. Cortex Pharmaceuticals is the leading manufacturer of ampakines.
Aniracetam is a supplement used to stimulate alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors in the brain. It is also known as Draganon, Sarpul, and Ampamet. Chemically, it is a member of the racetam class of compounds, which have a pyrrolidone nucleus at their core.
This compound is sold in Europe as a prescription drug, and in the United States as a dietary supplement. It is considered a nootropic compound, which means that it is intended to increase mental function. Nootropic drugs are also known as cognition enhancers. The mechanism of action of aniracetam is unknown, but clinical trials of the drug in animals have shown it to have anxiolytic or anxiolytic effects. These claims have not been verified by the US Food and Drug Administration (FDA).
Aniracetam is similar in structure and function to the compound piracetam, but aniracetam has a much higher fat solubility. This means that it has a greater ability to penetrate the brain through the blood-brain barrier and, as a result, has longer lasting effects. Both drugs have been used in the treatment of Alzheimer’s disease, and both have low toxicity. Aniracetam is considered to be three to ten times more potent than piracetam.
The RDA for this supplement is between 750 and 3,000 milligrams (mg). This medicine can be taken in one large dose or two smaller doses over the course of a day. It can cause side effects, such as headaches and nausea.
Aniracetam is the parent drug for all manufactured compounds that affect AMPA receptors, which are known as ampacins. These substances increase attention span and alertness, in addition to improving memory. Ampacins are considered stimulants, but they do not produce the same type of side effects as other stimulants, such as caffeine and Ritalin, after prolonged use.
Ampacins have been investigated as potential treatments for Parkinson’s disease, Alzheimer’s disease, and attention deficit hyperactivity disorder (ADHD). A 2006 study showed that these compounds have a lingering effect, even after being expelled from the body. Both memory and cognition also continued to improve in the test subjects, even in the absence of ampakines.
The most prominent manufacturer of ampakines is Cortex Pharmaceuticals, which holds patents for many of the medical uses of this class of drugs. Two of their most popular brands include Ampalex and Farampator. Since the beginning of their development program, the potency of these drugs has increased fivefold. Other companies have also developed aniracetam-based ampacins, but they are used in animal trials.
Protect your devices with Threat Protection by NordVPN
